title: Successful treatment with omalizumab in challenge confirmed exercise-induced anaphylaxis.
authors.affiliation: Department of Dermatology and Allergy Center, Odense Research Center for Anaphylaxis (ORCA), Odense University Hospital, University of Southern Denmark, Odense C, Denmark. Electronic address: morten.junker.christensen@rsyd.dk.
authors.forename: Morten J
authors.initials: MJ
authors.lastname: Christensen
authors.affiliation: Department of Dermatology and Allergy Center, Odense Research Center for Anaphylaxis (ORCA), Odense University Hospital, University of Southern Denmark, Odense C, Denmark.
authors.forename: Carsten
authors.initials: C
authors.lastname: Bindslev-Jensen
mesh_terms: D000293:Adolescent; D000707:Anaphylaxis / Q000175:diagnosis* / Q000188:drug therapy; D000799:Angioedema; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D001250:Asthma, Exercise-Induced / Q000175:diagnosis* / Q000188:drug therapy; D004837:Epinephrine / Q000008:administration & dosage; D005080:Exercise Test; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology / Q000378:metabolism; D007167:Immunotherapy / Q000379:methods*; D008297:Male; D000069444:Omalizumab / Q000627:therapeutic use*; D012882:Skin Tests; D013177:Sports; D016896:Treatment Outcome
chemical_list: D018926:Anti-Allergic Agents; D000069444:Omalizumab; D007073:Immunoglobulin E; D004837:Epinephrine